CLONIDINE TRANSDERMAL SYSTEM

CLONIDINE TRANSDERMAL SYSTEM was reported 2134 times

CLONIDINE TRANSDERMAL SYSTEM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE EXCORIATION 5 0.0769
1 ANTIDEPRESSANT DRUG LEVEL 1 0.0556
2 INSOMNIA RELATED TO ANOTHER MENTAL CONDITION 1 0.0417
3 APPLICATION SITE MASS 10 0.0365
4 ANAL SPHINCTER HYPERTONIA 1 0.0345
5 ENDOSCOPY GASTROINTESTINAL ABNORMAL 1 0.0303
6 FABRY'S DISEASE 1 0.0286
7 APPLICATION SITE BURNING 3 0.0286
8 APPLICATION SITE PHOTOSENSITIVITY REACTION 1 0.0270
9 CEREBRAL ATHEROSCLEROSIS 1 0.0256
10 APPLICATION SITE BLEEDING 6 0.0243
11 WITHDRAWAL HYPERTENSION 4 0.0198
12 BLOOD ARSENIC INCREASED 1 0.0185
13 BLOOD PRESSURE DIFFERENCE OF EXTREMITIES 1 0.0172
14 APPLICATION SITE HAEMATOMA 3 0.0164
15 APPLICATION SITE PRURITUS 347 0.0153
16 APPLICATION SITE RASH 198 0.0144
17 APPLICATION SITE SCAR 18 0.0144
18 DRUG WITHDRAWAL MAINTENANCE THERAPY 2 0.0142
19 BLOOD PRESSURE INADEQUATELY CONTROLLED 83 0.0138
20 MUSCLE FIBROSIS 1 0.0137
21 APPLICATION SITE DERMATITIS 12 0.0128
22 APPLICATION SITE VESICLES 83 0.0128
23 DEVICE PACING ISSUE 1 0.0118
24 APPLICATION SITE INDURATION 2 0.0118
25 INCARCERATED UMBILICAL HERNIA 1 0.0116
26 APPLICATION SITE ERYTHEMA 304 0.0116
27 NATURAL KILLER CELL COUNT DECREASED 1 0.0109
28 APPLICATION SITE BURN 53 0.0107
29 BACTERIA URINE 1 0.0104
30 BUNDLE BRANCH BLOCK BILATERAL 1 0.0104
31 AORTIC BRUIT 1 0.0104
32 APPLICATION SITE PAPULES 11 0.0104
33 APPLICATION SITE URTICARIA 23 0.0102
34 EYE INFARCTION 1 0.0100
35 APPLICATION SITE IRRITATION 123 0.0099
36 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
37 INTERCAPILLARY GLOMERULOSCLEROSIS 1 0.0095
38 APPLICATION SITE HYPERSENSITIVITY 11 0.0091
39 CONGENITAL JAW MALFORMATION 1 0.0088
40 APPLICATION SITE DISCHARGE 10 0.0087
41 APPLICATION SITE INFLAMMATION 12 0.0087
42 GALLOP RHYTHM PRESENT 1 0.0084
43 BREAST INFECTION 1 0.0083
44 BALANITIS 1 0.0082
45 DENTAL PROSTHESIS USER 1 0.0079
46 BLOOD TESTOSTERONE FREE DECREASED 1 0.0076
47 APPLICATION SITE DISCOLOURATION 30 0.0074
48 APPLICATION SITE NODULE 1 0.0073
49 APPLICATION SITE ODOUR 1 0.0069
50 APPLICATION SITE SWELLING 33 0.0066
51 FEEDING TUBE COMPLICATION 2 0.0064
52 SKIN FIBROSIS 3 0.0062
53 AUTONOMIC DYSREFLEXIA 1 0.0062
54 APPLICATION SITE DISCOMFORT 11 0.0061
55 APPLICATION SITE WOUND 1 0.0061
56 BLOOD FOLATE INCREASED 1 0.0060
57 BLOOD ALDOSTERONE INCREASED 1 0.0057
58 BASOPHIL PERCENTAGE INCREASED 1 0.0057
59 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1 0.0057
60 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
61 GAMMOPATHY 1 0.0055
62 APPLICATION SITE PUSTULES 2 0.0055
63 APPLICATION SITE INJURY 1 0.0053
64 PRODUCT ADHESION ISSUE 187 0.0052
65 GAMMA-GLUTAMYLTRANSFERASE DECREASED 1 0.0052
66 BONE SARCOMA 1 0.0052
67 ALCOHOLIC PANCREATITIS 1 0.0051
68 DROP ATTACKS 3 0.0051
69 KUSSMAUL RESPIRATION 1 0.0048
70 BACTERIA URINE IDENTIFIED 1 0.0047
71 APPLICATION SITE REACTION 33 0.0047
72 APPLICATION SITE EROSION 6 0.0047
73 PRODUCT WITH QUALITY ISSUE ADMINISTERED 2 0.0045
74 ACID BASE BALANCE ABNORMAL 1 0.0045
75 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
76 DILATATION ATRIAL 5 0.0043
77 APPLICATION SITE ACNE 2 0.0041
78 LATEX ALLERGY 1 0.0041
79 ERYTHEMA INFECTIOSUM 1 0.0039
80 APPLICATION SITE SCAB 8 0.0037
81 APPLICATION SITE PAIN 81 0.0037
82 LABILE HYPERTENSION 1 0.0036
83 GENITAL BLISTER 1 0.0036
84 DERMAL ABSORPTION IMPAIRED 1 0.0036
85 SICK SINUS SYNDROME 4 0.0035
86 HYPEROSMOLAR STATE 1 0.0035
87 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
88 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
89 CATHETER SITE CELLULITIS 1 0.0034
90 APPLICATION SITE EXFOLIATION 14 0.0034
91 PITTING OEDEMA 2 0.0033
92 CAUSTIC INJURY 1 0.0032
93 APPLICATION SITE OEDEMA 1 0.0031
94 NEPHROGENIC SYSTEMIC FIBROSIS 9 0.0030
95 HYPERALDOSTERONISM 1 0.0029
96 PRODUCT DESIGN ISSUE 2 0.0028
97 CERVICAL POLYP 1 0.0026
98 DEATH OF RELATIVE 1 0.0025
99 MASKED FACIES 1 0.0025
100 BLADDER PROLAPSE 3 0.0025
101 PERITONEAL DIALYSIS 2 0.0024
102 DRUG WITHDRAWAL HEADACHE 1 0.0024
103 SKIN INDURATION 5 0.0024
104 MELANOMA RECURRENT 1 0.0024
105 VASCULAR DEMENTIA 2 0.0023
106 NECK DEFORMITY 1 0.0023
107 HAEMORRHOID OPERATION 1 0.0022
108 FIBROADENOMA OF BREAST 1 0.0022
109 MULTIPLE DRUG OVERDOSE ACCIDENTAL 1 0.0022
110 PRODUCT APPEARANCE CONFUSION 2 0.0022
111 IMMUNOGLOBULINS INCREASED 1 0.0021
112 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
113 APPLICATION SITE BRUISE 2 0.0021
114 ECZEMA NUMMULAR 1 0.0020
115 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
116 APPLICATION SITE INFECTION 1 0.0020
117 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1 0.0019
118 DEVICE INEFFECTIVE 2 0.0019
119 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
120 UTERINE PROLAPSE 2 0.0018
121 ENCEPHALOMALACIA 1 0.0018
122 APPLICATION SITE DRYNESS 6 0.0018
123 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
124 CHEMICAL BURN 2 0.0017
125 AORTIC CALCIFICATION 1 0.0017
126 BLOOD PRESSURE INCREASED 254 0.0017
127 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
128 HELICOBACTER GASTRITIS 2 0.0016
129 EXCORIATION 4 0.0016
130 APPLICATION SITE WARMTH 2 0.0016
131 EXTREMITY CONTRACTURE 1 0.0016
132 RENAL FAILURE CHRONIC 12 0.0016
133 INFUSION SITE URTICARIA 1 0.0015
134 DERMATITIS CONTACT 17 0.0015
135 CHOREOATHETOSIS 1 0.0015
136 TONGUE DRY 2 0.0015
137 URETERIC OBSTRUCTION 2 0.0015
138 APPLICATION SITE HAEMORRHAGE 4 0.0015
139 FEELING OF RELAXATION 1 0.0015
140 EPISCLERITIS 1 0.0014
141 CUSHING'S SYNDROME 1 0.0014
142 MENISCUS LESION 2 0.0014
143 SKIN HYPERTROPHY 4 0.0014
144 DEVICE ELECTRICAL FINDING 1 0.0014
145 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
146 APPLICATION SITE ULCER 1 0.0014
147 MYOFASCIAL PAIN SYNDROME 1 0.0014
148 HYPERPHOSPHATAEMIA 3 0.0014
149 CARDIAC ENZYMES INCREASED 1 0.0014
150 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
151 FIBROCYSTIC BREAST DISEASE 1 0.0014
152 BLUNTED AFFECT 1 0.0014
153 HYPOAESTHESIA FACIAL 2 0.0013
154 PRODUCT SIZE ISSUE 7 0.0013
155 ARTERIAL RUPTURE 1 0.0013
156 PRODUCT RESIDUE PRESENT 7 0.0013
157 DRUG TOLERANCE INCREASED 1 0.0013
158 GRIMACING 1 0.0013
159 LABORATORY TEST INTERFERENCE 1 0.0013
160 ELECTROMECHANICAL DISSOCIATION 1 0.0013
161 EROSIVE DUODENITIS 1 0.0013
162 BLOOD PRESSURE FLUCTUATION 30 0.0012
163 GINGIVAL INFECTION 1 0.0012
164 AORTIC VALVE DISEASE 2 0.0012
165 COLONIC POLYP 2 0.0012
166 FRACTURE DELAYED UNION 1 0.0012
167 MALIGNANT HYPERTENSION 1 0.0012
168 CORONARY ARTERY DISSECTION 1 0.0012
169 CYSTOCELE 1 0.0012
170 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
171 PRODUCT TAMPERING 2 0.0011
172 RENAL TRANSPLANT 4 0.0011
173 ANAEMIA OF CHRONIC DISEASE 1 0.0011
174 HEART TRANSPLANT 1 0.0011
175 GASTRIC OPERATION 1 0.0011
176 MUSCLE SWELLING 1 0.0011
177 MICROANGIOPATHY 1 0.0011
178 SKIN TIGHTNESS 5 0.0011
179 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
180 ACTINOMYCOSIS 1 0.0010
181 COLON NEOPLASM 1 0.0010
182 COLON ADENOMA 1 0.0010
183 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
184 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
185 FIBROSIS 3 0.0010
186 DIASTOLIC DYSFUNCTION 3 0.0010
187 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
188 DRUG EFFECT INCREASED 3 0.0009
189 BURNS THIRD DEGREE 1 0.0009
190 NASAL INFLAMMATION 1 0.0009
191 JOINT CONTRACTURE 1 0.0009
192 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
193 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
194 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
195 COMPLEX PARTIAL SEIZURES 1 0.0009
196 CATHETER RELATED COMPLICATION 1 0.0009
197 DRUG EFFECT VARIABLE 1 0.0009
198 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
199 CARBON DIOXIDE DECREASED 1 0.0009
200 ADMINISTRATION SITE PAIN 1 0.0009
201 CAROTID ARTERY STENOSIS 3 0.0009
202 BLOOD PRESSURE ABNORMAL 17 0.0009
203 INCISION SITE PAIN 1 0.0009
204 NEPHROCALCINOSIS 1 0.0008
205 BLEEDING TIME PROLONGED 1 0.0008
206 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
207 SCAR 14 0.0008
208 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
209 BLADDER DISCOMFORT 1 0.0008
210 VENTRICULAR HYPERTROPHY 2 0.0008
211 SEDATION COMPLICATION 2 0.0008
212 PRODUCT COLOUR ISSUE 4 0.0008
213 BLOOD CHLORIDE DECREASED 2 0.0008
214 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
215 APPLICATION SITE PARAESTHESIA 1 0.0008
216 ASPERGILLOSIS 1 0.0008
217 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
218 ANION GAP INCREASED 1 0.0007
219 MUCOUS MEMBRANE DISORDER 1 0.0007
220 ECCHYMOSIS 5 0.0007
221 SINUS BRADYCARDIA 7 0.0007
222 ECHOCARDIOGRAM ABNORMAL 1 0.0007
223 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
224 CONNECTIVE TISSUE DISORDER 1 0.0007
225 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
226 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
227 DRUG EFFECT DECREASED 37 0.0007
228 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
229 HYPERTENSION 145 0.0007
230 URINE ANALYSIS ABNORMAL 2 0.0007
231 METABOLIC ENCEPHALOPATHY 2 0.0007
232 ASTIGMATISM 1 0.0007
233 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
234 DRUG ABUSER 4 0.0007
235 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
236 GASTRITIS EROSIVE 3 0.0006
237 NASAL DRYNESS 4 0.0006
238 ANTICHOLINERGIC SYNDROME 1 0.0006
239 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
240 FAECAL INCONTINENCE 3 0.0006
241 ANOREXIA 8 0.0006
242 VULVOVAGINAL DRYNESS 2 0.0006
243 PRODUCT QUALITY ISSUE 83 0.0006
244 BRADYARRHYTHMIA 1 0.0006
245 MITRAL VALVE PROLAPSE 1 0.0006
246 CORONARY ARTERY STENOSIS 3 0.0006
247 PRODUCT LABEL ISSUE 4 0.0006
248 MICTURITION DISORDER 2 0.0006
249 MITRAL VALVE DISEASE 1 0.0006
250 METAMORPHOPSIA 1 0.0005
251 BLOOD PRESSURE DECREASED 36 0.0005
252 LOBAR PNEUMONIA 1 0.0005
253 CHRONIC SINUSITIS 2 0.0005
254 PROTEIN TOTAL DECREASED 2 0.0005
255 INFECTED SKIN ULCER 1 0.0005
256 HYPERCOAGULATION 1 0.0005
257 DRUG DISPENSING ERROR 8 0.0005
258 CORONARY ARTERY BYPASS 3 0.0005
259 GINGIVAL DISORDER 2 0.0005
260 MOTION SICKNESS 1 0.0005
261 ARTERIAL THROMBOSIS 1 0.0005
262 CONCOMITANT DISEASE PROGRESSION 1 0.0005
263 ANORECTAL DISORDER 1 0.0005
264 PHARMACEUTICAL PRODUCT COMPLAINT 13 0.0005
265 MIOSIS 4 0.0005
266 UTERINE CANCER 4 0.0005
267 INTRACRANIAL ANEURYSM 2 0.0005
268 DEVICE RELATED SEPSIS 1 0.0005
269 MUCOSAL DRYNESS 1 0.0005
270 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 100 0.0005
271 IMPULSE-CONTROL DISORDER 1 0.0005
272 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
273 ACCIDENTAL EXPOSURE 2 0.0005
274 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
275 DERMATITIS ALLERGIC 6 0.0005
276 HYPERKINESIA 1 0.0005
277 BUNDLE BRANCH BLOCK LEFT 2 0.0005
278 AORTIC VALVE INCOMPETENCE 2 0.0005
279 MEDICATION ERROR 26 0.0005
280 FACIAL PALSY 1 0.0005
281 CARDIAC MURMUR 4 0.0005
282 EXPOSED BONE IN JAW 1 0.0005
283 HEART RATE DECREASED 16 0.0005
284 RESPIRATORY RATE INCREASED 4 0.0005
285 HYPERTENSIVE CRISIS 5 0.0004
286 FEAR OF DEATH 1 0.0004
287 MITRAL VALVE INCOMPETENCE 5 0.0004
288 SCAB 5 0.0004
289 SKIN IRRITATION 20 0.0004
290 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
291 MENOPAUSAL SYMPTOMS 1 0.0004
292 RENAL FAILURE ACUTE 18 0.0004
293 PRODUCT PACKAGING ISSUE 4 0.0004
294 MYOPIA 1 0.0004
295 LACUNAR INFARCTION 1 0.0004
296 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
297 DIABETIC NEUROPATHY 2 0.0004
298 ABDOMINAL TENDERNESS 2 0.0004
299 HEART RATE IRREGULAR 9 0.0004
300 HYPOTHERMIA 4 0.0004
301 AORTIC ANEURYSM 3 0.0004
302 AORTIC ARTERIOSCLEROSIS 1 0.0004
303 LIPOMA 1 0.0004
304 SEDATION 10 0.0004
305 EXFOLIATIVE RASH 1 0.0004
306 NASAL DISCOMFORT 3 0.0004
307 BLOOD ALBUMIN DECREASED 3 0.0004
308 TRICUSPID VALVE INCOMPETENCE 3 0.0004
309 BRADYCARDIA 20 0.0004
310 PHARYNGOLARYNGEAL PAIN 2 0.0004
311 JOINT RANGE OF MOTION DECREASED 5 0.0004
312 DRY MOUTH 30 0.0004
313 ABDOMINAL RIGIDITY 1 0.0004
314 ANORGASMIA 1 0.0004
315 HYPERAESTHESIA 3 0.0004
316 BLOOD UREA INCREASED 6 0.0004
317 ANGIOPATHY 2 0.0004
318 DRUG TOLERANCE DECREASED 1 0.0004
319 SKIN REACTION 5 0.0004
320 REBOUND EFFECT 4 0.0004
321 HYPERTONIA 2 0.0003
322 HYPERTONIC BLADDER 1 0.0003
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
324 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
325 ESCHERICHIA SEPSIS 1 0.0003
326 HAEMOTHORAX 1 0.0003
327 GASTROINTESTINAL NECROSIS 1 0.0003
328 LUMBAR SPINAL STENOSIS 1 0.0003
329 HYPOVOLAEMIA 2 0.0003
330 SINUS HEADACHE 2 0.0003
331 CREPITATIONS 1 0.0003
332 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
333 INFUSION SITE REACTION 1 0.0003
334 RASH ERYTHEMATOUS 16 0.0003
335 DERMATITIS 7 0.0003
336 TYPE 1 DIABETES MELLITUS 2 0.0003
337 HYPERCAPNIA 1 0.0003
338 NOCTURIA 4 0.0003
339 MASTICATION DISORDER 1 0.0003
340 DUODENITIS 1 0.0003
341 ECTOPIC PREGNANCY 1 0.0003
342 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
343 PIGMENTATION DISORDER 2 0.0003
344 FAMILY STRESS 1 0.0003
345 BLOOD BLISTER 1 0.0003
346 ABDOMINAL ADHESIONS 1 0.0003
347 BLADDER PAIN 1 0.0003
348 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
349 HERPES SIMPLEX 2 0.0003
350 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
351 LISTLESS 1 0.0003
352 TOOTH INFECTION 4 0.0003
353 PRODUCT FORMULATION ISSUE 2 0.0003
354 ANXIETY DISORDER 1 0.0003
355 BREAST MASS 2 0.0003
356 COLITIS ISCHAEMIC 2 0.0003
357 PRODUCT SUBSTITUTION ISSUE 17 0.0003
358 RESPIRATION ABNORMAL 2 0.0003
359 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
360 FEELING COLD 8 0.0003
361 HYPERKALAEMIA 10 0.0003
362 FRUSTRATION 1 0.0003
363 FACIAL BONES FRACTURE 1 0.0003
364 BONE LESION 1 0.0003
365 TONGUE DISORDER 2 0.0003
366 FLUID OVERLOAD 4 0.0003
367 OESOPHAGITIS 3 0.0003
368 FOOD INTOLERANCE 1 0.0003
369 ALCOHOL USE 1 0.0003
370 CARDIOMYOPATHY 4 0.0003
371 MEDICAL DEVICE COMPLICATION 2 0.0003
372 VENTRICULAR FIBRILLATION 3 0.0003
373 NERVOUSNESS 14 0.0003
374 BLISTER 15 0.0003
375 IMPULSIVE BEHAVIOUR 1 0.0003
376 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
377 BLOOD SODIUM DECREASED 5 0.0003
378 HEART RATE INCREASED 26 0.0003
379 WITHDRAWAL SYNDROME 11 0.0003
380 SKIN DISCOLOURATION 12 0.0003
381 LETHARGY 15 0.0003
382 POST PROCEDURAL COMPLICATION 5 0.0003
383 PHARYNGEAL OEDEMA 4 0.0003
384 HYPOTENSION 52 0.0003
385 ELECTROLYTE IMBALANCE 3 0.0003
386 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
387 DRUG SCREEN POSITIVE 2 0.0003
388 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
389 HAEMATOCRIT DECREASED 5 0.0003
390 HYPERLIPIDAEMIA 3 0.0003
391 WRIST FRACTURE 3 0.0003
392 FOREIGN BODY 1 0.0002
393 CANDIDIASIS 1 0.0002
394 BLEPHARITIS 1 0.0002
395 STENT PLACEMENT 2 0.0002
396 PRODUCT PHYSICAL ISSUE 5 0.0002
397 VENTRICULAR TACHYCARDIA 4 0.0002
398 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
399 EOSINOPHIL COUNT INCREASED 2 0.0002
400 HAEMODIALYSIS 2 0.0002
401 HALLUCINATIONS, MIXED 1 0.0002
402 INFUSION SITE ERYTHEMA 2 0.0002
403 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
404 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
405 LUNG NEOPLASM 1 0.0002
406 SKIN HYPERPIGMENTATION 2 0.0002
407 RASH GENERALISED 6 0.0002
408 PRURITUS GENERALISED 5 0.0002
409 PYELONEPHRITIS 2 0.0002
410 MONOPLEGIA 1 0.0002
411 OEDEMA PERIPHERAL 28 0.0002
412 ORTHOSTATIC HYPOTENSION 4 0.0002
413 BLOOD CALCIUM INCREASED 2 0.0002
414 DYSPHEMIA 1 0.0002
415 HAEMORRHAGIC ANAEMIA 1 0.0002
416 GINGIVAL SWELLING 1 0.0002
417 WRONG DRUG ADMINISTERED 2 0.0002
418 PALLOR 6 0.0002
419 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
420 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
421 ABDOMINAL HERNIA 1 0.0002
422 NIGHT SWEATS 7 0.0002
423 GRAND MAL CONVULSION 2 0.0002
424 PRODUCT DISTRIBUTION ISSUE 2 0.0002
425 FEELING OF DESPAIR 1 0.0002
426 THERAPEUTIC RESPONSE DECREASED 13 0.0002
427 BURNING SENSATION 15 0.0002
428 PALPITATIONS 25 0.0002
429 ARTERIOSCLEROSIS 2 0.0002
430 DRUG INEFFECTIVE 280 0.0002
431 CONVULSION 12 0.0002
432 APHAGIA 1 0.0002
433 ATELECTASIS 2 0.0002
434 ENTEROCOCCAL INFECTION 1 0.0002
435 DIZZINESS POSTURAL 2 0.0002
436 PRESYNCOPE 5 0.0002
437 HAEMORRHOIDS 4 0.0002
438 TREMOR 34 0.0002
439 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
440 INCORRECT DOSAGE ADMINISTERED 1 0.0002
441 RASH PRURITIC 11 0.0002
442 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
443 MUCOUS STOOLS 1 0.0002
444 ANEURYSM 1 0.0002
445 ECONOMIC PROBLEM 3 0.0002
446 DRUG TOLERANCE 1 0.0002
447 PLEURAL EFFUSION 12 0.0002
448 SLUGGISHNESS 2 0.0002
449 DRUG ADMINISTRATION ERROR 6 0.0002
450 INCREASED UPPER AIRWAY SECRETION 1 0.0002
451 CACHEXIA 1 0.0002
452 TEMPERATURE INTOLERANCE 2 0.0002
453 FAILURE TO THRIVE 1 0.0002
454 VENTRICULAR EXTRASYSTOLES 2 0.0002
455 CARDIO-RESPIRATORY ARREST 8 0.0002
456 ANHEDONIA 5 0.0002
457 BLOOD LACTIC ACID INCREASED 1 0.0002
458 HALLUCINATION, VISUAL 4 0.0002
459 ANORECTAL DISCOMFORT 1 0.0002
460 SENSORY DISTURBANCE 3 0.0002
461 BRUXISM 1 0.0002
462 MUSCLE TIGHTNESS 3 0.0002
463 BLOOD POTASSIUM INCREASED 3 0.0002
464 SKIN LACERATION 2 0.0002
465 ASPIRATION 2 0.0002
466 JAW DISORDER 1 0.0002
467 FAECALOMA 1 0.0002
468 DRUG LEVEL INCREASED 3 0.0002
469 MENTAL STATUS CHANGES 5 0.0002
470 STEVENS-JOHNSON SYNDROME 4 0.0002
471 HEART RATE ABNORMAL 1 0.0002
472 SOMNOLENCE 36 0.0002
473 CHEST PAIN 33 0.0002
474 FISTULA 2 0.0002
475 CEREBROVASCULAR ACCIDENT 30 0.0002
476 GRANULOCYTOPENIA 1 0.0002
477 CARDIAC VALVE DISEASE 1 0.0002
478 BLOOD URIC ACID INCREASED 1 0.0002
479 HYPERCHLORHYDRIA 1 0.0002
480 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
481 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
482 ENERGY INCREASED 1 0.0002
483 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
484 OSTEOMYELITIS 3 0.0002
485 HYPERGLYCAEMIA 6 0.0002
486 INGUINAL HERNIA 1 0.0002
487 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
488 LARYNGEAL OEDEMA 1 0.0002
489 ILEUS 2 0.0002
490 INFUSION SITE EXTRAVASATION 1 0.0002
491 DIZZINESS 80 0.0002
492 INFUSION SITE SWELLING 1 0.0002
493 BRAIN OEDEMA 2 0.0002
494 MUSCULOSKELETAL DISORDER 3 0.0002
495 FEELING JITTERY 3 0.0002
496 SLEEP APNOEA SYNDROME 3 0.0002
497 COMPLETED SUICIDE 13 0.0002
498 MYDRIASIS 2 0.0002
499 CARDIAC FLUTTER 1 0.0002
500 EAR PAIN 3 0.0002
501 SKIN BURNING SENSATION 11 0.0002
502 HEADACHE 96 0.0002
503 BRADYPHRENIA 1 0.0002
504 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
505 BEDRIDDEN 2 0.0002
506 GASTRITIS 4 0.0002
507 DYSGRAPHIA 1 0.0002
508 STAPHYLOCOCCAL INFECTION 5 0.0002
509 PRURITUS 58 0.0002
510 APPETITE DISORDER 1 0.0002
511 UPPER LIMB FRACTURE 3 0.0002
512 SPINAL FRACTURE 3 0.0001
513 SWELLING 14 0.0001
514 MALIGNANT MELANOMA 2 0.0001
515 RASH 65 0.0001
516 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
517 QUALITY OF LIFE DECREASED 2 0.0001
518 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
519 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
520 BODY TEMPERATURE INCREASED 3 0.0001
521 DRUG TOXICITY 2 0.0001
522 IMPAIRED GASTRIC EMPTYING 2 0.0001
523 AKATHISIA 2 0.0001
524 CROHN'S DISEASE 1 0.0001
525 NEPHROTIC SYNDROME 1 0.0001
526 CORONARY ARTERY OCCLUSION 2 0.0001
527 SKIN LESION 4 0.0001
528 PERIPHERAL COLDNESS 2 0.0001
529 HYPERSENSITIVITY 27 0.0001
530 JOINT EFFUSION 1 0.0001
531 PERITONITIS 3 0.0001
532 LYMPHOEDEMA 1 0.0001
533 NIGHTMARE 5 0.0001
534 HAIR GROWTH ABNORMAL 1 0.0001
535 HYPOGLYCAEMIA 7 0.0001
536 PULMONARY HYPERTENSION 3 0.0001
537 LARGE INTESTINE PERFORATION 1 0.0001
538 FORMICATION 1 0.0001
539 COORDINATION ABNORMAL 2 0.0001
540 URTICARIA 24 0.0001
541 EXTRASYSTOLES 1 0.0001
542 NECK PAIN 8 0.0001
543 CARPAL TUNNEL SYNDROME 2 0.0001
544 INJURY 10 0.0001
545 CONSTIPATION 31 0.0001
546 TARDIVE DYSKINESIA 4 0.0001
547 DIALYSIS 2 0.0001
548 DIVERTICULUM 1 0.0001
549 BRONCHOSPASM 2 0.0001
550 SUBDURAL HAEMATOMA 2 0.0001
551 ANGINA PECTORIS 4 0.0001
552 POOR QUALITY SLEEP 3 0.0001
553 MOBILITY DECREASED 10 0.0001
554 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
555 MYELODYSPLASTIC SYNDROME 2 0.0001
556 FLUID RETENTION 7 0.0001
557 GASTROENTERITIS 2 0.0001
558 ANXIETY 39 0.0001
559 DYSSTASIA 4 0.0001
560 CARDIAC FAILURE CONGESTIVE 11 0.0001
561 ACCIDENTAL OVERDOSE 5 0.0001
562 AGITATION 10 0.0001
563 RASH MACULO-PAPULAR 3 0.0001
564 RASH PAPULAR 3 0.0001
565 PANCREATITIS 7 0.0001
566 CORONARY ARTERY DISEASE 4 0.0001
567 OSTEOPENIA 2 0.0001
568 INSOMNIA 35 0.0001
569 HAEMODYNAMIC INSTABILITY 1 0.0001
570 ACIDOSIS 1 0.0001
571 HIP ARTHROPLASTY 2 0.0001
572 BOWEL MOVEMENT IRREGULARITY 1 0.0001
573 DEVICE ADHESION ISSUE 2 0.0001
574 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
575 DEVICE RELATED INFECTION 2 0.0001
576 EMOTIONAL DISORDER 4 0.0001
577 LYMPHOMA 2 0.0001
578 BLOOD CHOLESTEROL INCREASED 6 0.0001
579 HYPOALBUMINAEMIA 1 0.0001
580 THERAPY PARTIAL RESPONDER 2 0.0001
581 HAEMORRHAGIC STROKE 1 0.0001
582 SLEEP DISORDER 9 0.0001
583 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
584 AFFECTIVE DISORDER 1 0.0001
585 PRODUCT USE COMPLAINT 2 0.0001
586 ERYTHEMA 26 0.0001
587 MYOCARDIAL INFARCTION 22 0.0001
588 HALLUCINATION, AUDITORY 2 0.0001
589 GINGIVAL PAIN 1 0.0001
590 CYSTITIS 4 0.0001
591 OBESITY 2 0.0001
592 SEPSIS 14 0.0001
593 SCIATICA 2 0.0001
594 ATRIAL FLUTTER 1 0.0001
595 FEELING ABNORMAL 30 0.0001
596 HYPERHIDROSIS 16 0.0001
597 VISION BLURRED 17 0.0001
598 MUSCULAR WEAKNESS 14 0.0001
599 ASTHENIA 46 0.0001
600 METASTASES TO BONE 2 0.0001
601 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
602 EXTRAPYRAMIDAL DISORDER 3 0.0001
603 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
604 ACUTE CORONARY SYNDROME 1 0.0001
605 MUSCLE INJURY 1 0.0001
606 POLLAKIURIA 5 0.0001
607 URINARY RETENTION 4 0.0001
608 HOT FLUSH 9 0.0001
609 DRUG USE DISORDER 1 0.0001
610 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
611 FACE OEDEMA 2 0.0001
612 INADEQUATE ANALGESIA 1 0.0001
613 METRORRHAGIA 2 0.0001
614 CARDIAC OPERATION 1 0.0001
615 SKIN ULCER 3 0.0001
616 BALANCE DISORDER 10 0.0001
617 NEUROPATHY PERIPHERAL 11 0.0001
618 DISCOMFORT 7 0.0001
619 PARAESTHESIA 18 0.0001
620 RASH MACULAR 4 0.0001
621 JOINT STIFFNESS 3 0.0001
622 GROIN PAIN 1 0.0001
623 GRIP STRENGTH DECREASED 1 0.0001
624 HYPOXIA 4 0.0001
625 COLD SWEAT 2 0.0001
626 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
627 FACIAL PAIN 1 0.0001
628 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
629 FEAR 3 0.0001
630 THROAT IRRITATION 5 0.0001
631 PAIN OF SKIN 3 0.0001
632 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
633 OEDEMA 6 0.0001
634 ANAEMIA 21 0.0001
635 CRYING 4 0.0001
636 TREATMENT NONCOMPLIANCE 6 0.0001
637 UNDERDOSE 8 0.0001
638 INCORRECT DOSE ADMINISTERED 25 0.0001
639 EXOSTOSIS 1 0.0001
640 RESTLESSNESS 4 0.0001
641 CARDIAC ARREST 9 0.0001
642 RESPIRATORY ARREST 3 0.0001
643 TINNITUS 5 0.0001
644 RESPIRATORY DISTRESS 3 0.0001
645 BLOOD GLUCOSE ABNORMAL 2 0.0001
646 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
647 EYE SWELLING 4 0.0001
648 SWELLING FACE 7 0.0001
649 WOUND 3 0.0001
650 DEFORMITY 1 0.0001
651 LACERATION 1 0.0001
652 PAIN IN JAW 3 0.0001
653 HYPOCALCAEMIA 2 0.0001
654 COLITIS 4 0.0001
655 FOOT FRACTURE 2 0.0001
656 BLOOD URINE PRESENT 2 0.0001
657 HYPERSOMNIA 3 0.0001
658 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
659 MUSCLE SPASMS 19 0.0001
660 ERUCTATION 2 0.0001
661 ATRIAL FIBRILLATION 10 0.0001
662 DYSPHONIA 6 0.0001
663 COELIAC DISEASE 1 0.0001
664 ACUTE MYOCARDIAL INFARCTION 3 0.0001
665 LABORATORY TEST ABNORMAL 3 0.0001
666 URINARY INCONTINENCE 3 0.0001
667 LIGAMENT SPRAIN 1 0.0001
668 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
669 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
670 SINUS DISORDER 2 0.0001
671 ABNORMAL BEHAVIOUR 4 0.0001
672 CATARACT 6 0.0001
673 HYPOTONIA 1 0.0001
674 BLOOD POTASSIUM DECREASED 3 0.0001
675 GAIT DISTURBANCE 19 0.0001
676 CELLULITIS 5 0.0001
677 EMPHYSEMA 1 0.0001
678 VERTIGO 6 0.0001
679 DRY THROAT 1 0.0001
680 DRUG LEVEL DECREASED 1 0.0001
681 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
682 DEHYDRATION 13 0.0001
683 LIMB DISCOMFORT 3 0.0001
684 DEPRESSION 22 0.0001
685 EYE DISCHARGE 1 0.0001
686 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
687 PRODUCT USE ISSUE 18 0.0001
688 ROAD TRAFFIC ACCIDENT 4 0.0001
689 SPEECH DISORDER 5 0.0001
690 RENAL IMPAIRMENT 8 0.0001
691 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
692 INCONTINENCE 1 0.0001
693 OSTEOARTHRITIS 4 0.0001
694 BODY HEIGHT DECREASED 1 0.0001
695 MOVEMENT DISORDER 3 0.0001
696 DECREASED ACTIVITY 1 0.0001
697 DEEP VEIN THROMBOSIS 6 0.0001
698 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
699 BIPOLAR DISORDER 1 0.0001
700 BACK INJURY 1 0.0001
701 BLOOD CREATININE INCREASED 6 0.0001
702 PRODUCT PRESCRIBING ISSUE 2 0.0001
703 CHOLELITHIASIS 3 0.0001
704 BLOOD GLUCOSE FLUCTUATION 1 0.0001
705 RENAL FAILURE 12 0.0001
706 VISUAL ACUITY REDUCED 3 0.0001
707 FOOT DEFORMITY 1 0.0001
708 DYSPNOEA 51 0.0001
709 TACHYCARDIA 8 0.0001
710 TOOTH DISORDER 2 0.0001
711 MALNUTRITION 1 0.0001
712 PULMONARY OEDEMA 4 0.0001
713 SNEEZING 2 0.0001
714 INTESTINAL PERFORATION 1 0.0001
715 BLOOD CALCIUM DECREASED 1 0.0001
716 IMPAIRED DRIVING ABILITY 1 0.0001
717 HAEMATURIA 3 0.0001
718 CHOLECYSTECTOMY 1 0.0001
719 HYPOAESTHESIA 13 0.0001
720 MUSCLE TWITCHING 2 0.0001
721 HYPOKALAEMIA 4 0.0001
722 METASTASES TO LUNG 1 0.0001
723 DELIRIUM 3 0.0001
724 ABDOMINAL DISTENSION 9 0.0001
725 PRODUCT DOSE OMISSION ISSUE 25 0.0001
726 ARRHYTHMIA 4 0.0001
727 MACULAR DEGENERATION 1 0.0001
728 MULTIPLE SCLEROSIS 4 0.0001
729 CONTUSION 8 0.0001
730 SKIN EXFOLIATION 7 0.0001
731 EMOTIONAL DISTRESS 10 0.0001
732 MENTAL IMPAIRMENT 2 0.0001
733 RESPIRATORY FAILURE 6 0.0001
734 NEURALGIA 2 0.0001
735 URINARY TRACT INFECTION 14 0.0001
736 MUSCLE SPASTICITY 1 0.0001
737 CARDIOMEGALY 1 0.0001
738 BRONCHITIS 6 0.0001
739 ABASIA 2 0.0001
740 CYST 1 0.0001
741 CONFUSIONAL STATE 13 0.0001
742 PRODUCT STORAGE ERROR 7 0.0001
743 SYNCOPE 8 0.0001
744 DRUG WITHDRAWAL SYNDROME 7 0.0001
745 DYSARTHRIA 3 0.0001
746 WEIGHT DECREASED 22 0.0001
747 CHEST DISCOMFORT 8 0.0001
748 FALL 26 0.0001
749 LOSS OF CONSCIOUSNESS 10 0.0001
750 INFUSION SITE PAIN 1 0.0001
751 UNRESPONSIVE TO STIMULI 2 0.0001
752 FATIGUE 60 0.0001
753 AMNESIA 5 0.0001
754 PRODUCT DOSE OMISSION 5 0.0001
755 MUSCULOSKELETAL PAIN 4 0.0001
756 INCORRECT PRODUCT STORAGE 1 0.0001
757 DISORIENTATION 3 0.0001
758 ADVERSE REACTION 1 0.0001
759 EAR INFECTION 2 0.0001
760 EYE HAEMORRHAGE 1 0.0001
761 BREAST CANCER FEMALE 2 0.0001
762 HAIR TEXTURE ABNORMAL 1 0.0001
763 JOINT SWELLING 9 0.0001
764 DYSKINESIA 3 0.0001
765 LIMB INJURY 2 0.0001
766 MIGRAINE 7 0.0001
767 MASS 1 0.0001
768 BLOOD TEST ABNORMAL 1 0.0001
769 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
770 PNEUMONIA 23 0.0001
771 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
772 HYPONATRAEMIA 4 0.0001
773 BLINDNESS UNILATERAL 1 0.0001
774 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
775 FLATULENCE 4 0.0001
776 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
777 RED BLOOD CELL COUNT DECREASED 2 0.0001
778 CARDIOGENIC SHOCK 1 0.0001
779 PANCREATIC CARCINOMA 2 0.0001
780 FLUSHING 7 0.0001
781 MUSCULOSKELETAL STIFFNESS 6 0.0001
782 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
783 DRY SKIN 9 0.0001
784 COLON CANCER 1 0.0001
785 RESPIRATORY DISORDER 2 0.0001
786 HALLUCINATION 5 0.0001
787 UNEVALUABLE EVENT 5 0.0001
788 ILL-DEFINED DISORDER 4 0.0001
789 DIABETES MELLITUS 5 0.0001
790 FEELING HOT 4 0.0001
791 NAUSEA 51 0.0001
792 RENAL DISORDER 3 0.0001
793 DELUSION 1 0.0001
794 EJECTION FRACTION DECREASED 1 0.0001
795 COUGH 18 0.0001
796 CARDIAC DISORDER 6 0.0001
797 NERVOUS SYSTEM DISORDER 2 0.0001
798 SWOLLEN TONGUE 2 0.0001
799 VOMITING 30 0.0001
800 BLOOD GLUCOSE INCREASED 12 0.0001
801 ARTHRITIS 5 0.0001
802 OCULAR HYPERAEMIA 3 0.0001
803 HEAD INJURY 2 0.0001
804 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
805 COMA 3 0.0001
806 HYPOTHYROIDISM 2 0.0001
807 METABOLIC ACIDOSIS 2 0.0001
808 BLOOD GLUCOSE DECREASED 3 0.0001
809 INTENTIONAL OVERDOSE 4 0.0001
810 ALOPECIA 12 0.0001
811 PAIN IN EXTREMITY 18 0.0001
812 IMPAIRED HEALING 2 0.0001
813 OSTEONECROSIS 2 0.0001
814 EYE DISORDER 2 0.0001
815 MANIA 1 0.0001
816 BACK PAIN 14 0.0001
817 EXPIRED PRODUCT ADMINISTERED 2 0.0001
818 DRY EYE 3 0.0001
819 DRUG ABUSE 5 0.0001
820 LIP SWELLING 2 0.0001
821 FUNGAL INFECTION 2 0.0001
822 SKIN DISORDER 2 0.0001
823 AGGRESSION 3 0.0001
824 EYE PRURITUS 2 0.0001
825 ANGER 2 0.0001
826 HEMIPARESIS 1 0.0001
827 HAEMOGLOBIN DECREASED 6 0.0001
828 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
829 MUSCULOSKELETAL DISCOMFORT 1 0.0001
830 WEIGHT INCREASED 13 0.0001
831 MULTI-ORGAN FAILURE 1 0.0001
832 DEVICE DEFECTIVE 1 0.0001
833 LOCAL SWELLING 1 0.0001
834 DEVICE USE ISSUE 1 0.0001
835 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
836 DEVICE MALFUNCTION 4 0.0001
837 DEPRESSED MOOD 3 0.0001
838 PLATELET COUNT DECREASED 6 0.0001
839 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
840 GALLBLADDER DISORDER 1 0.0001
841 DECREASED APPETITE 13 0.0001
842 OFF LABEL USE 49 0.0001
843 CONDITION AGGRAVATED 17 0.0001
844 GASTROENTERITIS VIRAL 1 0.0001
845 LEUKOCYTOSIS 1 0.0001
846 DRUG EFFECT INCOMPLETE 2 0.0001
847 PANIC ATTACK 2 0.0001
848 ANAPHYLACTIC REACTION 3 0.0001
849 ADVERSE EVENT 5 0.0001
850 DYSGEUSIA 4 0.0001
851 HEPATIC STEATOSIS 1 0.0001
852 THROMBOCYTOPENIA 6 0.0001
853 BACTERIAL INFECTION 1 0.0001
854 MIDDLE INSOMNIA 1 0.0001
855 EPISTAXIS 4 0.0001
856 OXYGEN SATURATION DECREASED 3 0.0001
857 EYE PAIN 3 0.0001
858 DYSPNOEA EXERTIONAL 2 0.0001
859 ASTHMA 6 0.0001
860 INTESTINAL OBSTRUCTION 2 0.0001
861 MYALGIA 9 0.0001
862 INCREASED APPETITE 1 0.0001
863 CHOLESTASIS 1 0.0001
864 ACUTE RESPIRATORY FAILURE 1 0.0001
865 GLAUCOMA 1 0.0001
866 DRUG INTOLERANCE 5 0.0001
867 HERNIA 1 0.0001
868 DYSTONIA 1 0.0001
869 CHILLS 6 0.0001
870 SURGERY 3 0.0001
871 NASAL CONGESTION 3 0.0001
872 OVERDOSE 11 0.0001
873 KIDNEY INFECTION 1 0.0001
874 DYSPEPSIA 5 0.0001
875 PAIN 31 0.0001
876 IRRITABILITY 3 0.0000
877 BONE MARROW FAILURE 1 0.0000
878 LUNG NEOPLASM MALIGNANT 2 0.0000
879 OSTEOPOROSIS 2 0.0000
880 ABDOMINAL PAIN UPPER 10 0.0000
881 MALAISE 21 0.0000
882 HAEMORRHAGE 5 0.0000
883 EATING DISORDER 1 0.0000
884 JOINT INJURY 1 0.0000
885 IRRITABLE BOWEL SYNDROME 1 0.0000
886 SEPTIC SHOCK 2 0.0000
887 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
888 ANGIOEDEMA 2 0.0000
889 NEOPLASM MALIGNANT 3 0.0000
890 THERAPY NON-RESPONDER 2 0.0000
891 DRUG INTERACTION 7 0.0000
892 SUICIDAL IDEATION 4 0.0000
893 MEMORY IMPAIRMENT 6 0.0000
894 NASOPHARYNGITIS 8 0.0000
895 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
896 DYSPHAGIA 4 0.0000
897 DISEASE RECURRENCE 2 0.0000
898 PRODUCTIVE COUGH 2 0.0000
899 DIARRHOEA 27 0.0000
900 DIABETIC KETOACIDOSIS 1 0.0000
901 TOXICITY TO VARIOUS AGENTS 7 0.0000
902 LOCALISED INFECTION 1 0.0000
903 CEREBRAL INFARCTION 1 0.0000
904 ARTHRALGIA 17 0.0000
905 LIVER INJURY 1 0.0000
906 LEUKOPENIA 2 0.0000
907 HAEMATEMESIS 1 0.0000
908 CARDIOVASCULAR DISORDER 1 0.0000
909 HEPATITIS 1 0.0000
910 PERIPHERAL SWELLING 6 0.0000
911 ERECTILE DYSFUNCTION 1 0.0000
912 ABDOMINAL PAIN 9 0.0000
913 HAEMATOMA 1 0.0000
914 DRUG DEPENDENCE 6 0.0000
915 DISTURBANCE IN ATTENTION 2 0.0000
916 FREQUENT BOWEL MOVEMENTS 1 0.0000
917 MOOD ALTERED 1 0.0000
918 DIVERTICULITIS 1 0.0000
919 HAEMOPTYSIS 1 0.0000
920 ABDOMINAL DISCOMFORT 6 0.0000
921 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
922 HERPES ZOSTER 2 0.0000
923 LIVER FUNCTION TEST ABNORMAL 1 0.0000
924 INTENTIONAL PRODUCT MISUSE 3 0.0000
925 BONE PAIN 2 0.0000
926 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
927 ASCITES 1 0.0000
928 WHEEZING 2 0.0000
929 HEPATIC FAILURE 1 0.0000
930 LACRIMATION INCREASED 1 0.0000
931 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
932 SUICIDE ATTEMPT 2 0.0000
933 STOMATITIS 2 0.0000
934 OROPHARYNGEAL PAIN 3 0.0000
935 FEMUR FRACTURE 1 0.0000
936 BONE DENSITY DECREASED 1 0.0000
937 MOOD SWINGS 1 0.0000
938 HIP FRACTURE 1 0.0000
939 RHINORRHOEA 2 0.0000
940 LACTIC ACIDOSIS 1 0.0000
941 INFUSION RELATED REACTION 2 0.0000
942 SINUSITIS 3 0.0000
943 NEOPLASM PROGRESSION 1 0.0000
944 LYMPHADENOPATHY 1 0.0000
945 THERAPY INTERRUPTED 2 0.0000
946 CEREBRAL HAEMORRHAGE 1 0.0000
947 NO ADVERSE EVENT 5 0.0000
948 DYSURIA 1 0.0000
949 PYREXIA 9 0.0000
950 SEIZURE 3 0.0000
951 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
952 ABORTION SPONTANEOUS 1 0.0000
953 PROSTATE CANCER 2 0.0000
954 EXTRA DOSE ADMINISTERED 1 0.0000
955 DEVICE BREAKAGE 1 0.0000
956 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
957 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
958 HYPOACUSIS 1 0.0000
959 DEVICE LEAKAGE 1 0.0000
960 MENTAL DISORDER 1 0.0000
961 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
962 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
963 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
964 PULMONARY EMBOLISM 2 0.0000
965 INFECTION 3 0.0000
966 INTERSTITIAL LUNG DISEASE 1 0.0000
967 LUNG DISORDER 1 0.0000
968 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
969 ILLNESS 2 0.0000
970 ECZEMA 1 0.0000
971 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
972 DEPENDENCE 1 0.0000
973 HAEMATOCHEZIA 1 0.0000
974 ARTHROPATHY 1 0.0000
975 EYE IRRITATION 1 0.0000
976 DISEASE PROGRESSION 2 0.0000
977 VISUAL IMPAIRMENT 2 0.0000
978 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
979 ACNE 1 0.0000
980 CHRONIC KIDNEY DISEASE 1 0.0000
981 HOSPITALISATION 2 0.0000
982 DEATH 11 0.0000
983 CARDIAC FAILURE 1 0.0000
984 INFLUENZA LIKE ILLNESS 1 0.0000
985 GASTROINTESTINAL DISORDER 1 0.0000
986 DEVICE ISSUE 1 0.0000
987 ADVERSE DRUG REACTION 1 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
989 INFLUENZA 1 0.0000
990 ACUTE KIDNEY INJURY 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000